WGO apparently unpaid research has a target price of 70c and yet it is still 25c. Maybe Byron has a reason to complain and be upset with WGO sp.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%